Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications

• Autores principales: Gian Luca Erre (Autor), Marco Sebastiani (Autor), Andreina Manfredi (Autor), Elisabetta Gerratana (Autor), Fabiola Atzeni (Autor), Giuseppe Passiu (Autor), Arduino A Mangoni (Autor)
• Formato: Libro
• Publicado: BioExcel Publishing Ltd, 2021-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Fibrosing interstitial lung disease (ILD) is one of the most important causes of morbidity and mortality in patients with connective tissue diseases (CTDs), which include systemic sclerosis, rheumatoid arthritis, Sjögren's syndrome, idiopathic inflammatory myositis and systemic lupus erythemato...